A Randomized, Open-label, Single Dose, 1-sequence, 3-treatment, 3-period Crossover Study to Investigate the Effects of Food on the Pharmacokinetics/Pharmacodynamics of CKD-519 in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 28 Feb 2017
At a glance
- Drugs CKD 519 (Primary) ; CKD 519 (Primary)
- Indications Dyslipidaemias
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
- 21 Feb 2017 Status changed from active, no longer recruiting to completed.
- 23 Nov 2016 Planned End Date changed from 1 Nov 2016 to 1 Feb 2017.
- 23 Nov 2016 Status changed from recruiting to active, no longer recruiting.